Michael Rudloff
@MRudloffMSTP
MD/PhD student @VanderbiltMSTP | Views are my own
ID:1277055577731072000
28-06-2020 01:46:01
36 Tweets
164 Followers
217 Following
Happy to present our latest paper in Cancer Immunology Research from Jess Roetman, PhD 🏳️🌈, the whole Philip Lab team and Drs. Youngmin Lee and Ting-Fang Less VUMC Surgical Sciences !
#OnlineFirst : Tumor-reactive CD8+ #Tcells enter a TCF1+PD1– dysfunctional state, by Jess Roetman, PhD 🏳️🌈, Mary Philip et al.
bit.ly/3MxT9w1
Minna Apostolova Vanderbilt School of Medicine
Congratulations to Jess Roetman, PhD 🏳️🌈, Megan Erwin , Michael Rudloff , Philip Lab, and everyone else involved on putting this story together! 🎉 A really interesting perspective on how antigen origin impacts T cells!
.VUMC Pathology researchers have demonstrated that a cluster of microRNAs — small pieces of RNA that regulate gene expression — work in a type of immune cells called macrophages to help protect against metabolic defects in obesity.
Cell Reports Pua Lab
spr.ly/6018PxCEj
Excited to share our findings on early CD8+ T cell differentiation in tumors! Dysfunction can occur just hours after activation and coincides with large scale chromatin remodeling prior to cell division. Philip Lab Vanderbilt MSTP Check out link below 👇
We are excited to share our work published today in Nature Immunology by Michael Rudloff, the whole @PhilipLabVandy team Vanderbilt University Medical Center, and in collaboration with our fantastic computational biology collaborators Doron Betel and his group Weill Cornell Medicine. 1/7
nature.com/articles/s4159…
#ScienceSaturday When does T cell dysfunction start? It turns out, within hours of contacting tumor and even before T cell proliferation! Intriguing article by Michael Rudloff, Mary Philip and colleagues Vanderbilt Hem / Onc demonstrating this and hypothesizing that this may be due to
Really excited to share the work I have done with Haydn Kissick over my PhD! In this work we show that CD8 T cell activation and differentiation in cancer happens in two distinct phases. Tweet-orial below summarizes the main findings we have described. cell.com/immunity/fullt…
Very happy to share our work on T cells in one of the deadliest side effects of anti-cancer therapy, immune checkpoint inhibitor-myocarditis out today in nature mentored by BalkoResearchLab Javid Moslehi ; read on for a short summary! Vanderbilt MSTP
nature.com/articles/s4158…
Excited to share our latest preprint from the Jeff Rathmell lab! We found that fever temperatures alter CD4 T cell metabolism and are mutagenic. Thanks to all coauthors for their help in this exciting project!😁
Postoak et al. describe a novel role for the lipid kinase Vps34 in controlling the production of self-peptides optimized for selection of CD4 but not CD8 T cells. bit.ly/3chRE63
From our #Tolerance & #Autoimmunity collection: bit.ly/3s1wMnT